100% efficacy to ombitasvir/paritaprevir/ritonavir ( ± dasabuvir) with or without ribavirin in hepatitis C virus genotypes 1 and 4-infected hemodialysis patients

Authors :: A. Aseeri
Abdullah S. Alghamdi
Faisal M. Sanai
A. Afghani
K.A. Alswat
Mohammed A. Babatin
Source :: Journal of Hepatology. 66:S312
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Hepatology
business.industry
Hepatitis C virus
medicine.medical_treatment
Ribavirin
medicine.disease_cause
Virology
Ombitasvir/Paritaprevir/ Ritonavir/Dasabuvir
chemistry.chemical_compound
chemistry
Genotype
medicine
Hemodialysis
business

Full Text Access

Tools